198 related articles for article (PubMed ID: 35579417)
1. Structure of the IL-27 quaternary receptor signaling complex.
Caveney NA; Glassman CR; Jude KM; Tsutsumi N; Garcia KC
Elife; 2022 May; 11():. PubMed ID: 35579417
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into the assembly and activation of the IL-27 signaling complex.
Jin Y; Fyfe PK; Gardner S; Wilmes S; Bubeck D; Moraga I
EMBO Rep; 2022 Oct; 23(10):e55450. PubMed ID: 35920255
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of activation and antagonism of receptor signaling mediated by interleukin-27.
Składanowska K; Bloch Y; Strand J; White KF; Hua J; Aldridge D; Welin M; Logan DT; Soete A; Merceron R; Murphy C; Provost M; Bazan JF; Hunter CA; Hill JA; Savvides SN
Cell Rep; 2022 Oct; 41(3):111490. PubMed ID: 36261006
[TBL] [Abstract][Full Text] [Related]
4. The composition and signaling of the IL-35 receptor are unconventional.
Collison LW; Delgoffe GM; Guy CS; Vignali KM; Chaturvedi V; Fairweather D; Satoskar AR; Garcia KC; Hunter CA; Drake CG; Murray PJ; Vignali DA
Nat Immunol; 2012 Feb; 13(3):290-9. PubMed ID: 22306691
[TBL] [Abstract][Full Text] [Related]
5. An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer.
Garbers C; Spudy B; Aparicio-Siegmund S; Waetzig GH; Sommer J; Hölscher C; Rose-John S; Grötzinger J; Lorenzen I; Scheller J
J Biol Chem; 2013 Feb; 288(6):4346-54. PubMed ID: 23209286
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-induced gene 3 (EBI3) can mediate IL-6
Chehboun S; Labrecque-Carbonneau J; Pasquin S; Meliani Y; Meddah B; Ferlin W; Sharma M; Tormo A; Masson JF; Gauchat JF
J Biol Chem; 2017 Apr; 292(16):6644-6656. PubMed ID: 28280243
[TBL] [Abstract][Full Text] [Related]
7. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
8. Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses.
Wilmes S; Jeffrey PA; Martinez-Fabregas J; Hafer M; Fyfe PK; Pohler E; Gaggero S; López-García M; Lythe G; Taylor C; Guerrier T; Launay D; Mitra S; Piehler J; Molina-París C; Moraga I
Elife; 2021 Apr; 10():. PubMed ID: 33871355
[TBL] [Abstract][Full Text] [Related]
9. A role for IL-27p28 as an antagonist of gp130-mediated signaling.
Stumhofer JS; Tait ED; Quinn WJ; Hosken N; Spudy B; Goenka R; Fielding CA; O'Hara AC; Chen Y; Jones ML; Saris CJ; Rose-John S; Cua DJ; Jones SA; Elloso MM; Grötzinger J; Cancro MP; Levin SD; Hunter CA
Nat Immunol; 2010 Dec; 11(12):1119-26. PubMed ID: 21057510
[TBL] [Abstract][Full Text] [Related]
10. Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions.
Dahmen H; Horsten U; Küster A; Jacques Y; Minvielle S; Kerr IM; Ciliberto G; Paonessa G; Heinrich PC; Müller-Newen G
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):695-702. PubMed ID: 9560294
[TBL] [Abstract][Full Text] [Related]
11. Conservation of functional sites on interleukin-6 and implications for evolution of signaling complex assembly and therapeutic intervention.
Veverka V; Baker T; Redpath NT; Carrington B; Muskett FW; Taylor RJ; Lawson AD; Henry AJ; Carr MD
J Biol Chem; 2012 Nov; 287(47):40043-50. PubMed ID: 23027872
[TBL] [Abstract][Full Text] [Related]
12. The biology of interleukin-27 reveals unique pro- and anti-inflammatory functions in immunity.
Aparicio-Siegmund S; Garbers C
Cytokine Growth Factor Rev; 2015 Oct; 26(5):579-86. PubMed ID: 26195434
[TBL] [Abstract][Full Text] [Related]
13. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells.
Glassman CR; Mathiharan YK; Jude KM; Su L; Panova O; Lupardus PJ; Spangler JB; Ely LK; Thomas C; Skiniotis G; Garcia KC
Cell; 2021 Feb; 184(4):983-999.e24. PubMed ID: 33606986
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex.
Horsten U; Müller-Newen G; Gerhartz C; Wollmer A; Wijdenes J; Heinrich PC; Grötzinger J
J Biol Chem; 1997 Sep; 272(38):23748-57. PubMed ID: 9295319
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-35 in immune-related diseases: protection or destruction.
Zhang J; Zhang Y; Wang Q; Li C; Deng H; Si C; Xiong H
Immunology; 2019 May; 157(1):13-20. PubMed ID: 30681737
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-11 signals through the formation of a hexameric receptor complex.
Barton VA; Hall MA; Hudson KR; Heath JK
J Biol Chem; 2000 Nov; 275(46):36197-203. PubMed ID: 10948192
[TBL] [Abstract][Full Text] [Related]
18. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
19. Structural snapshots of full-length Jak1, a transmembrane gp130/IL-6/IL-6Rα cytokine receptor complex, and the receptor-Jak1 holocomplex.
Lupardus PJ; Skiniotis G; Rice AJ; Thomas C; Fischer S; Walz T; Garcia KC
Structure; 2011 Jan; 19(1):45-55. PubMed ID: 21220115
[TBL] [Abstract][Full Text] [Related]
20. Construction of unnatural heterodimeric receptors based on IL-2 and IL-6 receptor subunits.
Ogawa K; Kawahara M; Nagamune T
Biotechnol Prog; 2013; 29(6):1512-8. PubMed ID: 23926072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
